Influence of dominant sequence artifacts on generative AI for virtual contrast-enhancement in breast MRI.
Source check: Source checked. Not independent scientific confirmation.
Finding: In 1,974 breast MRI examinations, excluding DWI artifact-affected slices during pix2pix virtual contrast training produced only a small SSIM increase and no material improvement in lesion-level or reader-rated outcomes; strong inference-time artifacts were associated with higher lesion error. This is a technical limitation/result, not improved clinical diagnosis.
Technology: Pix2pix GAN generates virtual contrast-enhanced breast MRI from noncontrast sequences.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Pix2pix GAN generates virtual contrast-enhanced breast MRI from noncontrast sequences.
- Test and result
- Pix2pix GAN generates virtual contrast-enhanced breast MRI from noncontrast sequences.; In 1,974 breast MRI examinations, excluding DWI artifact-affected slices during pix2pix virtual contrast training produced only a small SSIM increase and no material improvement in lesion-level or reader-rated outcomes; strong inference-time artifacts were associated with higher lesion error. This is a technical limitation/result, not improved clinical diagnosis.; Retrospective evaluation compares artifact-ha
- Limitation / still unknown
- External generalization, independent replication and downstream real-world impact were not established by the reviewed source.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12880-026-02996-8
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.